FI931558L - Indolderivat - Google Patents

Indolderivat Download PDF

Info

Publication number: FI931558L
Authority: FI; Finland
Prior art keywords: indolderivatives
Prior art date: 1992-04-07

Application number

FI931558A

Other languages

English (en)

Finnish (fi)

Other versions

FI931558A0 (fi

FI931558A7 (fi

Inventor

John E Macor

Martin James Wythes

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-07

Filing date

1993-04-06

Publication date

1993-10-08

1993-04-06 Application filed by Pfizer filed Critical Pfizer

1993-04-06 Publication of FI931558A0 publication Critical patent/FI931558A0/fi

1993-10-08 Publication of FI931558L publication Critical patent/FI931558L/fi

1993-10-08 Publication of FI931558A7 publication Critical patent/FI931558A7/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Pyrrole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

FI931558A 1992-04-07 1993-04-06 Indolin johdannaisia FI931558A7 (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US86473792A	1992-04-07	1992-04-07

Publications (3)

Publication Number	Publication Date
FI931558A0 FI931558A0 (fi)	1993-04-06
FI931558L true FI931558L (fi)	1993-10-08
FI931558A7 FI931558A7 (fi)	1993-10-08

Family

ID=25343950

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI931558A FI931558A7 (fi)	1992-04-07	1993-04-06	Indolin johdannaisia

Country Status (26)

Country	Link
US (7)	US5747501A (es)
EP (1)	EP0635017A1 (es)
JP (1)	JP2644088B2 (es)
KR (1)	KR0179072B1 (es)
CN (2)	CN1050841C (es)
AU (1)	AU670579B2 (es)
BR (1)	BR9306201A (es)
CA (1)	CA2133413C (es)
CZ (1)	CZ281763B6 (es)
EG (1)	EG20226A (es)
FI (1)	FI931558A7 (es)
HR (1)	HRP930752A2 (es)
HU (1)	HUT64062A (es)
IL (1)	IL105206A (es)
MX (1)	MX9302011A (es)
MY (1)	MY108909A (es)
NO (1)	NO303388B1 (es)
NZ (1)	NZ251086A (es)
PL (1)	PL172405B1 (es)
RU (1)	RU2101283C1 (es)
SK (1)	SK280193B6 (es)
TW (1)	TW341565B (es)
UA (1)	UA27467C2 (es)
WO (1)	WO1993020073A1 (es)
YU (1)	YU48931B (es)
ZA (1)	ZA932440B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5559246A (en) *	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
US5545644A (en) *	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5607951A (en) *	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
US5559129A (en) *	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
US5578612A (en) *	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
UA27467C2 (uk) *	1992-04-07	2000-09-15	Пфайзер Інк.	ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
ES2070087B1 (es) *	1993-08-13	1996-02-16	Pfizer	Derivados de indol
DK0716649T3 (da) *	1993-08-31	1999-02-08	Pfizer	5-Arylindolderivater
EP0759918A1 (en) *	1994-05-19	1997-03-05	MERCK SHARP & DOHME LTD.	Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
GB9415575D0 (en) *	1994-08-02	1994-09-21	Merck Sharp & Dohme	Therapeutic agents
GB9417310D0 (en)	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
GB9420529D0 (en)	1994-10-12	1994-11-30	Pfizer Ltd	Indoles
GB9423682D0 (en) *	1994-11-23	1995-01-11	Merck Sharp & Dohme	Therapeutic agents
US6025374A (en) *	1994-12-06	2000-02-15	Merck Sharp & Dohme, Ltd.	Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor agonists
ATE236154T1 (de) *	1995-07-31	2003-04-15	Shionogi & Co	Pyrrolydin-derivate mit einer phospholipase a2 inhibierenden wirkung
GB9519558D0 (en) *	1995-09-26	1995-11-29	Merck Sharp & Dohme	Therapeutic agents
US6051593A (en) *	1997-06-20	2000-04-18	Sugen, Inc.	3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors
EP1100501A4 (en) *	1998-06-30	2002-12-04	Lilly Co Eli	PYRROLIDINE AND PYRROLIDINE DERIVATIVES INFLUENTING THE SYSTEMS ASSOCIATED WITH SEROTONIN
CA2339662A1 (en) *	1998-08-07	2000-02-17	Takeda Chemical Industries, Ltd.	Benzothiepin derivatives, their production and use
US5994352A (en) *	1998-11-13	1999-11-30	Pfizer Inc.	5-arylindole derivatives
US6326388B1 (en) *	1999-12-21	2001-12-04	Celgene Corporation	Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
PT1455779E (pt) *	2001-12-20	2006-11-30	Wyeth Corp	Derivados de indolilalquilamina como ligandos da 5-hidroxitriptamina-6
RU2218189C1 (ru) *	2002-05-28	2003-12-10	Нижегородская государственная медицинская академия	Способ лечения мигрени в межприступном периоде заболевания
US7041697B2 (en) *	2002-09-12	2006-05-09	Wyeth	Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
US7781426B2 (en) *	2005-12-30	2010-08-24	Merck Sharp & Dohme Corp.	CETP inhibitors
CN102186477B (zh) *	2008-10-16	2013-07-17	奥梅-杨森制药有限公司	作为代谢型谷氨酸受体调节剂的吲哚和苯并吗啉衍生物
US20100217013A1 (en) *	2008-12-15	2010-08-26	Wenge Li	Enantioselective process for the preparation of zolmitriptan
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
EP3447051B1 (en) *	2016-04-28	2021-12-15	Jiangsu Hengrui Medicine Co., Ltd.	Method for preparing tyrosine kinase inhibitor and derivative thereof
JP2023512821A (ja) *	2020-02-04	2023-03-29	マインドセットファーマインコーポレイテッド	中枢神経系障害の治療のためのセロトニン作動性幻覚薬としての３－ピロリジンインドール誘導体
WO2025104491A1 (en) *	2023-11-14	2025-05-22	Mindset Pharma Inc.	Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA795239B (en) *	1978-10-12	1980-11-26	Glaxo Group Ltd	Heterocyclic compounds
ZA815541B (en) *	1980-08-12	1983-03-30	Glaxo Group Ltd	Heterocyclic compounds
US4689336A (en) *	1981-01-02	1987-08-25	Pfizer Inc.	Hypoglycemic 5-substituted oxazolidine 2,4-diones
GB8600397D0 (en) *	1986-01-08	1986-02-12	Glaxo Group Ltd	Chemical compounds
FR2601008B1 (fr) *	1986-07-03	1990-03-30	Sanofi Sa	Procede de synthese stereospecifique de derives de l'indole
WO1988009661A1 (en) *	1987-06-10	1988-12-15	Pfizer Inc.	Oxazolidin-2-one derivatives as hypoglycemic agents
GB8719167D0 (en) *	1987-08-13	1987-09-23	Glaxo Group Ltd	Chemical compounds
GB8724912D0 (en) *	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
GB8819024D0 (en) *	1988-08-10	1988-09-14	Glaxo Group Ltd	Chemical compounds
IL96891A0 (en) *	1990-01-17	1992-03-29	Merck Sharp & Dohme	Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
MC2210A1 (fr) *	1990-06-07	1992-11-26	Wellcome Found	Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer
US5559129A (en)	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
US5559246A (en)	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
US5578612A (en)	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
ES2104733T3 (es) *	1990-10-15	1997-10-16	Pfizer	Derivados de indol.
US5607951A (en)	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
US5545644A (en)	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5208248A (en) *	1991-01-11	1993-05-04	Merck Sharpe & Dohme, Ltd.	Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) *	1991-02-01	1998-05-06	Merck Sharp & Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu, spôsob i
TW263508B (es) *	1991-02-12	1995-11-21	Pfizer
ATE190608T1 (de)	1991-11-25	2000-04-15	Pfizer	5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten
EP0545478A1 (en) *	1991-12-03	1993-06-09	MERCK SHARP & DOHME LTD.	Heterocyclic compounds as tachykinin antagonists
US5409941A (en)	1992-02-03	1995-04-25	Pfizer Inc.	5-heteroyl indole derivatives
TW288010B (es)	1992-03-05	1996-10-11	Pfizer
UA27467C2 (uk) *	1992-04-07	2000-09-15	Пфайзер Інк.	ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
CZ282653B6 (cs)	1992-04-10	1997-08-13	Pfizer Inc.	Acylaminoindolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy
JP7121942B2 (ja)	2018-04-10	2022-08-19	アサヒビール株式会社	発泡性飲料移充填方法
JP7121943B2 (ja)	2018-04-27	2022-08-19	日本ゼオン株式会社	レジストパターン形成方法

1993
- 1993-03-10 UA UA94105899A patent/UA27467C2/uk unknown
- 1993-03-10 US US08/295,798 patent/US5747501A/en not_active Expired - Fee Related
- 1993-03-10 NZ NZ251086A patent/NZ251086A/en unknown
- 1993-03-10 KR KR1019940703552A patent/KR0179072B1/ko not_active Expired - Fee Related
- 1993-03-10 PL PL93305555A patent/PL172405B1/pl not_active IP Right Cessation
- 1993-03-10 SK SK1206-94A patent/SK280193B6/sk unknown
- 1993-03-10 JP JP5517443A patent/JP2644088B2/ja not_active Expired - Fee Related
- 1993-03-10 RU RU94045897/04A patent/RU2101283C1/ru not_active IP Right Cessation
- 1993-03-10 WO PCT/US1993/001967 patent/WO1993020073A1/en not_active Ceased
- 1993-03-10 CA CA002133413A patent/CA2133413C/en not_active Expired - Fee Related
- 1993-03-10 BR BR9306201A patent/BR9306201A/pt not_active Application Discontinuation
- 1993-03-10 EP EP93907216A patent/EP0635017A1/en not_active Ceased
- 1993-03-10 CZ CZ942464A patent/CZ281763B6/cs not_active IP Right Cessation
- 1993-03-10 AU AU37898/93A patent/AU670579B2/en not_active Ceased
- 1993-03-29 IL IL10520693A patent/IL105206A/en not_active IP Right Cessation
- 1993-04-02 HR HR930752A patent/HRP930752A2/hr not_active Application Discontinuation
- 1993-04-05 EG EG20593A patent/EG20226A/xx active
- 1993-04-05 MY MYPI93000616A patent/MY108909A/en unknown
- 1993-04-05 ZA ZA932440A patent/ZA932440B/xx unknown
- 1993-04-06 FI FI931558A patent/FI931558A7/fi not_active IP Right Cessation
- 1993-04-06 HU HU9301003A patent/HUT64062A/hu unknown
- 1993-04-06 YU YU23893A patent/YU48931B/sh unknown
- 1993-04-06 MX MX9302011A patent/MX9302011A/es unknown
- 1993-04-06 CN CN93105697A patent/CN1050841C/zh not_active Expired - Fee Related
- 1993-04-09 TW TW082102651A patent/TW341565B/zh active
1994
- 1994-10-06 NO NO943762A patent/NO303388B1/no not_active IP Right Cessation
1998
- 1998-04-14 US US09/059,799 patent/US6150388A/en not_active Expired - Fee Related
- 1998-07-08 CN CN98116024A patent/CN1083443C/zh not_active Expired - Fee Related
2000
- 2000-10-23 US US09/694,394 patent/US6387937B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,588 patent/US6465500B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,808 patent/US6410739B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,809 patent/US6387941B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,387 patent/US6436957B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PL172405B1 (en)	1997-09-30
US5747501A (en)	1998-05-05
IL105206A0 (en)	1993-07-08
US6387941B1 (en)	2002-05-14
KR0179072B1 (ko)	1999-03-20
NZ251086A (en)	1996-09-25
MY108909A (en)	1996-11-30
MX9302011A (es)	1994-03-31
HU9301003D0 (en)	1993-06-28
IL105206A (en)	1999-04-11
CA2133413C (en)	2001-04-10
CA2133413A1 (en)	1993-10-14
US6436957B1 (en)	2002-08-20
US6410739B1 (en)	2002-06-25
NO943762D0 (no)	1994-10-06
EG20226A (en)	1997-12-31
SK120694A3 (en)	1995-05-10
US6150388A (en)	2000-11-21
RU2101283C1 (ru)	1998-01-10
HRP930752A2 (en)	1994-10-31
CZ246494A3 (en)	1995-06-14
YU23893A (sh)	1996-10-09
NO303388B1 (no)	1998-07-06
CZ281763B6 (cs)	1997-01-15
US6465500B1 (en)	2002-10-15
UA27467C2 (uk)	2000-09-15
JPH07504919A (ja)	1995-06-01
WO1993020073A1 (en)	1993-10-14
BR9306201A (pt)	1998-06-23
SK280193B6 (sk)	1999-09-10
TW341565B (en)	1998-10-01
CN1082543A (zh)	1994-02-23
AU3789893A (en)	1993-11-08
AU670579B2 (en)	1996-07-25
HUT64062A (en)	1993-11-29
NO943762L (no)	1994-10-06
CN1050841C (zh)	2000-03-29
KR950700906A (ko)	1995-02-20
JP2644088B2 (ja)	1997-08-25
US6387937B1 (en)	2002-05-14
FI931558A0 (fi)	1993-04-06
ZA932440B (en)	1994-10-05
FI931558A7 (fi)	1993-10-08
YU48931B (sh)	2002-12-10
EP0635017A1 (en)	1995-01-25
CN1083443C (zh)	2002-04-24
CN1225362A (zh)	1999-08-11
RU94045897A (ru)	1996-09-10

Publication	Publication Date	Title
FI930554L (fi)	1993-08-11	Organopolysiloxanbaserade loesgoeringskompositioner foer papper
DE59303358D1 (de)	1996-09-05	Quaterrylentetracarbonsäureimide
DE59306810D1 (de)	1997-07-31	Gutbettwalzenmühle
FI931558L (fi)	1993-10-08	Indolderivat
DE59302851D1 (de)	1996-07-11	Sportschuh
BR9305745A (pt)	1997-01-28	Quebra-luz
DE59301902D1 (de)	1996-04-18	Kassenlade
DE59305364D1 (de)	1997-03-13	Rotornut
DE69304512D1 (de)	1996-10-10	Laseroszillator
DE69306208D1 (de)	1997-01-09	Ablenkjoch
DE59304139D1 (de)	1996-11-14	Polyanile
ATA227792A (de)	1994-11-15	Sportschuh
BR9301712A (pt)	1993-11-03	Aplainador
DE59309200D1 (de)	1999-01-21	Bisphosphinoalkane
FI931255A0 (fi)	1993-03-22	Avisar/nedisar -aemne
DE59301762D1 (de)	1996-04-11	Chlorethylsulfonylbenzaldehyde
FI925186A0 (fi)	1992-11-16	Tvaohandspimpelspoe
FI383U1 (fi)	1992-11-23	Sprutbetongmunstycke
DE59206388D1 (de)	1996-06-27	Kabeleckkanal
FI213U1 (fi)	1992-08-11	Foderdoseringsanordning
ATA25994A (de)	1999-02-15	Alpinski
BR9201254A (pt)	1993-10-13	Jogo-olimpladas
BR9204074A (pt)	1993-04-13	Contramarco pre-moldano
BR9204065A (pt)	1994-04-26	Soprocóptero
BR9203563A (pt)	1994-03-22	Rotortranca

Legal Events

Date	Code	Title	Description
2005-10-31	MA	Patent expired